Trastornos de control de impulsos: adicciones conductuales en la enfermedad de Parkinson
Resumen
La enfermedad de Parkinson (EP) es un trastorno neurodegenerativo progresivo e incurable, que afecta con mayor frecuencia a personas de edad avanzada. Su diagnóstico es clínico y se basa en la aparición de varios síntomas motores como: temblor en reposo, bradicinesia, rigidez muscular e inestabilidad postural. Sin embargo, en las últimas décadas se ha reconocido que la EP también se manifiesta con síntomas no motores, entre los cuales se encuentran los trastornos de control de impulsos (TCI), los cuales se definen como conductas realizadas en forma impulsiva-compulsiva que pueden interferir en las principales áreas de funcionamiento de la vida de la persona, hasta el grado de causarle problemas físicos, psicológicos, sociales, jurídicos o financieros. Los TCI han sido vinculados con el uso de la terapia de reemplazo dopaminérgica, en especial de los agonistas de los receptores dopaminérgicos de tipo D3 como el pramipexol. Tradicionalmente cuatro tipos de comportamientos han sido reconocidos y clasificados como TCI y estos son: la hipersexualidad, las compras compulsivas, el juego patológico y la ingesta compulsiva de comida también llamada trastorno de atracones, sólo estos dos últimos están descritos en la edición más reciente del Manual Diagnóstico y Estadístico de los Trastornos Mentales (DSM-5). Por otro lado, existen otras manifestaciones que por sus similitudes neurobiológicas pueden ser consideradas también TCI o adicciones conductuales. En la presente revisión se presenta una somera descripción de las hipótesis acerca de la fisiopatología de los TCI, sus manifestaciones clínicas más importantes, los factores de riesgo para desarrollarlos y algunos abordajes terapéuticos.
Abstract: Parkinson's disease (PD) is a progressive incurable neurodegenerative disorder, which most often affects the elderly. The diagnosis is clinical and based on the appearance of various motor symptoms such as: rest tremor, bradykinesia, muscle stiffness and postural instability. However, in recent decades it has been recognized that PD also manifests with non-motor symptoms, among which are impulse control disorders (ICD), which are defined as impulsive-compulsive behaviors that can interfere in the main areas of functioning of the person's life, to the extent of causing physical, psychological, social, legal or financial problems. ICD have been linked to the use of dopamine replacement therapy, especially D3-type dopamine receptor agonists such as pramipexole. Traditionally, four types of behaviors have been recognized and classified as ICD and they are: hypersexuality, compulsive shopping, pathological gambling and compulsive food intake, also called binge eating disorder, only these last two are described in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). On the other hand, there are other manifestations that due to their neurobiological similarities can also be considered as IDC or behavioral addictions. This review presents a brief description of the hypotheses about the pathophysiology of ICD, its most important clinical manifestations, the risk factors for developing them, and some therapeutic approaches.
Keywords: Parkinson's disease; dopaminergic agonists; impulse control disorders; behavioral addictions.
Palabras clave
Referencias
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017; 3:1-21.
González Maldonado R, Morata Pérez JM y Luque Durán JD: Un ensayo sobre la parálisis agitante, Edición bilingüe: An essay on the shaking palsy (James Parkinson, 1817). Rafael González Maldonado (Editor), Madrid. 2013; pp.20-21.
Cronin Golomb A. Emergence of nonmotor symptoms as the focus of research and treatment of Parkinsons disease: Introduction to the special section on nonmotor dysfunctions in Parkinsons disease. Behav Neurosci. 2013; 127:135-8.
Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol. 2008; 64: S93-100.
Weintraub D, David AS, Evans AH, Grant JE, Stacy M. Clinical spectrum of impulse control disorders in Parkinson's disease. Mov Disord. 2015; 30:121-7.
Luo SX, Huang EJ. Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. Am J Pathol. 2016; 186:478-88.
Segarra AB, Banegas I, Prieto I, Ramírez-Sánchez M. Asimetría cerebral y dopamina: más allá de las implicaciones motoras en la enfermedad de Parkinson y hemiparkinsonismo experimental. Rev Neurol. 2016; 63: 415-21.
Adams RD, Victor M, Roope AH. Adams RD y Victor M (Eds): Principios de Neurología. Mcgraw Hill Interamericana, México. 2011; pp.1033-1045.
DeMaagd G, Philip A. Parkinson’s Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. PT. 2015; 40:504-532
Bhidayasiri R, Saksornchai K, Kaewwilai L, Phanthumchinda K. A census of movement disorders at a Thai university hospital. Journal of the Neurological Sciences 2011; 301:31–4.
Postuma RB, Gagnon JF, Montplaisir J. Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry. 2010; 81:1008-1013.
Munhoz RP, Moro A, Silveira-Moriyama L, Teive HA. Non-motor signs in Parkinson's disease: a review. Arq Neuropsiquiatr 2015; 73:454-62.
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review. Mov Disord. 2019; 34:180-198.
Balarajah S, Cavanna AE. The pathophysiology of impulse control disorders in Parkinson disease. Behav Neurol. 2013; 26:237-44.
Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron. 2009; 61:502-10.
Rodríguez-Violante M, González-Latapi P, Cervantes-Arriaga A, Camacho-Ordoñez A, Weintraub D. Impulse control and related disorders in Mexican Parkinson's disease patients. Parkinsonism Relat Disord. 2014; 20:907-10.
Claassen DO, van den Wildenberg WP, Harrison MB, van Wouwe NC, Kanoff K, Neimat JS, Wylie SA. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Pharmacol Biochem Behav. 2015; 129:19-25.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Publishing Incorporated, Arlington. 2013.
Gatto EM, Aldinio V. Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review. Front Neurol. 2019; 10:351.
Granero R, Fernández-Aranda F, Mestre-Bach G, Steward T, Baño M, Del Pino-Gutiérrez A, Moragas L, Mallorquí-Bagué N, Aymamí N, Gómez-Peña M, Tárrega S, Menchón JM, Jiménez-Murcia S. Compulsive Buying Behavior: Clinical Comparison with Other Behavioral Addictions. Front Psychol. 2016; 7:914.
Piquet-Pessôa M, Ferreira GM, Melca IA, Fontenelle LF. DSM-5 and the Decision Not to Include Sex, Shopping or Stealing as Addictions. Curr Addict Rep. 2014;1: 172–176.
Zou Z, Wang H, Uquillas FDO, Wang X, Ding J, Chen H. Definition of Substance and Non-substance Addiction Adv Exp Med Biol. 2017; 1010:21-41.
Potenza, M.N. Should addictive disorders include non-substancerelated conditions? Addiction. 2006; 101: 142–151.
Andreassen CS, Griffiths MD, Pallesen S, Bilder RM, Torsheim T, Aboujaoude E. The Bergen Shopping Addiction Scale: reliability and validity of a brief screening test. Front Psychol. 2015; 6:1374.
Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M. Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain. 2016; 139:1325-1347.
Cossu G, Rinaldi R, Colosimo C. The rise and fall of impulse control behavior disorders. Parkinsonism Relat Disord. 2018; 46: S24-S29.
Claassen DO, Stark AJ, Spears CA, Petersen KJ, van Wouwe NC, Kessler RM, Zald DH, Donahue MJ. Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors. Mov Disord. 2017; 32:1574-1583.
Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011; 69:680-694.
Everitt, B. J., Robbins, T. W. Neural systems of reinforcement for drug addiction, from action to habits to compulsion. Nature Neuroscience. 2005; 8:1481-1489.
Fernández-Serrano M, Perales-López J, Moreno-López L, Santos-Ruiz A, Pérez-García M, Verdejo-García A. Impulsividad y compulsividad en individuos dependientes de cocaína. Adicciones. 2012; 24:105-114.
Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis. 2013; 11:63-71.
Bahena-Trujillo R, Flores G, Arias-Montaño JA. Dopamine: synthesis, release and receptors in the central nervous system. Rev Biomed. 2000; 11:39-60.
Seeman P. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse. 2015; 69:183-189.
Vriend C. The neurobiology of impulse control disorders in Parkinson’s disease: from neurotransmitters to neural networks. Cell Tissue Res. 2018; 373:327-336.
Béreau M. Hypersexuality in Neurological Disorders: From Disinhibition to Impulsivity. Frontiers of Neurology and Neuroscience Neurologic-Psychiatric Syndromes in Focus Part I. Front Neurol Neurosci. 2018; 41:71-76.
Castellini G, Rellini AH, Appignanesi C, Appignanesi C, Pinucci I, Fattorini M, Grano E, Fisher A, Cassioli E, Lelli L, Maggi M, Ricca V. Deviance or Normalcy? The Relationship Among Paraphilic Thoughts and Behaviors, Hypersexuality, and Psychopathology in a Sample of University Students. J Sex Med. 2018; 15:1322-1335.
Gallagher DA, O’Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson’s disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord. 2007; 22:1757–63.
Lim S-Y, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson’s disease: review. Ann N Y Acad Sci. 2008; 1142:85–107.
Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P. J. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. Neurol Neurosurg Psychiatry. 2017; 88:317-324.
Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction. 2011; 106:283-293.
Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Arch Neurol. 2010;67 :589-95.
Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005; 66: 564–74.
Molde H, Moussavi Y, Kopperud ST, Erga AH, Hansen AL, Pallesen S. Impulse-Control Disorders in Parkinson's Disease: A Meta-Analysis and Review of Case-Control Studies. Front Neurol. 2018; 9:330.
Sáez-Francàs N, Martí Andrés G, Ramírez N, de Fàbregues O, Álvarez-Sabín J, Casas M, Hernández-Vara J. Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease. Neurologia. 2016; 31:231-8.
Isais-Millán S, Piña-Fuentes D, Guzmán-Astorga C, Cervantes-Arriaga A, Rodríguez-Violante M. Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD). Gac Med Mex. 2016; 152:357-63.
Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ. Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord. 2013; 28:327-33.
Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord. 2009; 24:1461-1467.
Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale. Mov Disord. 2012; 27:242-247.
Ramirez A, Gee L, Boyd J, Biller J. Treatment of impulse control disorders in Parkinson’s disease: Practical considerations and future directions. Expert Rev Neurother. 2016; 16:389-99.
Zhang G, Zhang Z, Liu L, Yang J, Huang J, Xiong N, Wang T. Impulsive and compulsive behaviors in Parkinson's disease. Front Aging Neurosci. 2014; 6:318.
Okai D, Askey-Jones S, Samuel M, O'Sullivan SS, Chaudhuri KR, Martin A, Mack J, Brown RG, David AS. Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology. 2013; 80:792-9.
Grant JE, Atmaca M, Fineberg NA, Fontenelle LF, Matsunaga H, Janardhan Reddy YC, Simpson HB, Thomsen PH, van den Heuvel OA, Veale D, Woods DW, Stein DJ. Impulse control disorders and “behavioural addictions” in the ICD-11. World Psychiatry. 2014; 13:125–7.
Weintraub D, Claassen DO. Impulse Control and Related Disorders in Parkinson’s Disease. Int Rev Neurobiol. 2017; 133:679-717
Starcevic V, Khazaal Y. Relationships between Behavioural Addictions and Psychiatric Disorders: What Is Known and What Is Yet to Be Learned? Front Psychiatry. 2017; 8:53.
DOI: https://doi.org/10.25009/eb.v11i27.2558
Enlaces refback
- No hay ningún enlace refback.
eNeurobiología es una publicación cuatrimestral editada por el Instituto de Investigaciones Cerebrales de la Universidad Veracruzana. Estamos ubicados en Av. Dr. Luis Castelazo Ayala, s/n, colonia Industrial Ánimas, C.P. 91190, Xalapa-Enríquez, Veracruz, México. Teléfono: 8418900 ext. 13062, www.iice.uv.mx; eneurobiologia@uv.mx. Reserva de Derechos al Uso Exclusivo 04-2023-061314100600-102, otorgada por el Instituto Nacional de Derechos de Autor. ISSN: 2007-3054. Esta obra está bajo una Licencia Creative Commons Attribution 4.0 International.